Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 4
2006 6
2007 7
2008 11
2009 8
2010 11
2011 10
2012 16
2013 15
2014 8
2015 9
2016 12
2017 12
2018 16
2019 9
2020 11
2021 9
2022 9
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

165 results

Results by year

Filters applied: . Clear all
Page 1
TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification.
Hoenisch Gravel N, Nelde A, Bauer J, Mühlenbruch L, Schroeder SM, Neidert MC, Scheid J, Lemke S, Dubbelaar ML, Wacker M, Dengler A, Klein R, Mauz PS, Löwenheim H, Hauri-Hohl M, Martin R, Hennenlotter J, Stenzl A, Heitmann JS, Salih HR, Rammensee HG, Walz JS. Hoenisch Gravel N, et al. Among authors: hennenlotter j. Nat Commun. 2023 Nov 17;14(1):7472. doi: 10.1038/s41467-023-42692-7. Nat Commun. 2023. PMID: 37978195 Free PMC article.
Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma.
Reustle A, Menig LS, Leuthold P, Hofmann U, Stühler V, Schmees C, Becker M, Haag M, Klumpp V, Winter S, Büttner FA, Rausch S, Hennenlotter J, Fend F, Scharpf M, Stenzl A, Bedke J, Schwab M, Schaeffeler E. Reustle A, et al. Among authors: hennenlotter j. Clin Transl Med. 2022 Jun;12(6):e883. doi: 10.1002/ctm2.883. Clin Transl Med. 2022. PMID: 35678045 Free PMC article.
Tissue microarrays in clinical urology--technical considerations.
Kramer MW, Merseburger AS, Hennenlotter J, Kuczyk M. Kramer MW, et al. Among authors: hennenlotter j. Scand J Urol Nephrol. 2007;41(6):478-84. doi: 10.1080/00365590701430737. Scand J Urol Nephrol. 2007. PMID: 17907050 Review.
A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy.
Büttner FA, Winter S, Stühler V, Rausch S, Hennenlotter J, Füssel S, Zastrow S, Meinhardt M, Toma M, Jerónimo C, Henrique R, Miranda-Gonçalves V, Kröger N, Ribback S, Hartmann A, Agaimy A, Stöhr C, Polifka I, Fend F, Scharpf M, Comperat E, Wasinger G, Moch H, Stenzl A, Gerlinger M, Bedke J, Schwab M, Schaeffeler E. Büttner FA, et al. Among authors: hennenlotter j. Genome Med. 2022 Sep 15;14(1):105. doi: 10.1186/s13073-022-01105-y. Genome Med. 2022. PMID: 36109798 Free PMC article.
Isolated, disseminated and circulating tumour cells in prostate cancer.
Schilling D, Todenhöfer T, Hennenlotter J, Schwentner C, Fehm T, Stenzl A. Schilling D, et al. Among authors: hennenlotter j. Nat Rev Urol. 2012 Aug;9(8):448-63. doi: 10.1038/nrurol.2012.136. Epub 2012 Jul 10. Nat Rev Urol. 2012. PMID: 22777287 Review.
Circulating fibronectin controls tumor growth.
von Au A, Vasel M, Kraft S, Sens C, Hackl N, Marx A, Stroebel P, Hennenlotter J, Todenhöfer T, Stenzl A, Schott S, Sinn HP, Wetterwald A, Bermejo JL, Cecchini MG, Nakchbandi IA. von Au A, et al. Among authors: hennenlotter j. Neoplasia. 2013 Aug;15(8):925-38. doi: 10.1593/neo.13762. Neoplasia. 2013. PMID: 23908593 Free PMC article.
Nomograms including the UBC® Rapid test to detect primary bladder cancer based on a multicentre dataset.
Meisl CJ, Karakiewicz PI, Einarsson R, Koch S, Hallmann S, Weiß S, Hemdan T, Malmström PU, Styrke J, Sherif A, Hasan MN, Pichler R, Tulchiner G, Palou J, Rodríguez Faba Ó, Hennenlotter J, Stenzl A, Ritter R, Niegisch G, Grunewald CM, Schlomm T, Friedersdorff F, Barski D, Otto T, Gössl A, Arndt C, Esuvaranathan K, Kesavan NR, Zhijiang Z, Kramer MW, Hennig MJP, Ecke TH. Meisl CJ, et al. Among authors: hennenlotter j. BJU Int. 2022 Dec;130(6):754-763. doi: 10.1111/bju.15677. Epub 2022 Jan 11. BJU Int. 2022. PMID: 34928524
Discriminative capacity of guideline recommendations in the assessment of patients with asymptomatic microhematuria.
Kuckuck EC, Hennenlotter J, Todenhöfer T, Brünn LA, Rass GC, Stenzl A, Hakenberg OW, Roghmann F, Goebell PJ, Grimm MO, Pycha A, Bolenz C, Burger M, Benderska-Söder N, Schmitz-Dräger BJ. Kuckuck EC, et al. Among authors: hennenlotter j. Urol Oncol. 2023 May;41(5):254.e1-254.e8. doi: 10.1016/j.urolonc.2022.08.011. Epub 2022 Oct 21. Urol Oncol. 2023. PMID: 36274029
165 results